Global NewsHigh Priority (8/10)Eswatini

UN Introduces Lenacapavir 'Miracle' Drug in Nine African Nations to Combat HIV

The United Nations is introducing lenacapavir, dubbed the 'miracle' drug, in nine high-risk African nations including Eswatini, offering hope to dramatically curb new HIV infections despite recent foreign aid cuts.

Key Points

  • Lenacapavir introduced in nine African nations including Eswatini
  • Drug administered as injection twice yearly for HIV prevention
  • Could dramatically curb new HIV infections and help end AIDS epidemic
  • Foreign aid cuts threaten HIV response programs globally

Full Details

The United Nations is rolling out lenacapavir, a long-acting antiretroviral injection being called a potential 'miracle' drug, in nine of the most at-risk African countries including Eswatini. The drug, administered as an injection twice yearly, represents a major advancement in HIV prevention and could help end the AIDS epidemic. However, the positive news comes amid significant challenges - last year's unprecedented foreign aid cuts by the Trump administration and other countries had previously funded around half of Eswatini's HIV response. These aid cuts have created the biggest disruptions ever to HIV response, affecting testing, treatment, and prevention programs. Without continued support, modeling suggests millions more deaths, infections, and medication-resistant strains could result.

Why It Matters

While lenacapavir represents a breakthrough in HIV prevention, the success of the rollout depends on sustained international funding amid ongoing aid reductions.

Sourceindependent.co.uk

Get stories like this delivered daily

AI-curated news, personalized to your interests. Zero noise.

Start 7-Day Free Trial →

More in Global News